42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-663263
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 8869d5d3-46d1-4458-a890-eb42913aab5e
[Document ID] => 663263
[Document naam] => Centrient Pharmaceuticals_EU pharma strategy response_Final Draft.pdf
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/document/VWS-WOO-08-663263
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-663263
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz
[DocumentPublicationDate] => 10 september 2020
[DocumentStatusCheckedDate] => 2026-04-28 10:51:13.856928
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 03:10:19
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 03:10:19
)
Document: VWS-WOO-08-663263
Klik om te vergroten
Document correcties
Geregistreerde datum: 20200910
Geregistreerde documentnaam: Centrient Pharmaceuticals_EU pharma strategy response_Final Draft.pdf
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang publicatie_linkname_1 | Inventarislijst | 2026-03-11 03:55:42 |
| Request_Omvang publicatie_paginas | 8.342 | 2026-03-11 03:55:42 |
| Request_Omvang publicatie | 8.342 documenten waarvan 4.012 openbaar gemaakt Inventarislijst | 2026-03-11 03:55:42 |
| Request_Omvang publicatie_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/file/download/inventory | 2026-03-11 03:55:42 |
| About_Gelakte gegevens | Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-02 08:08:22 |
| document_SectionDownloadButton | 1 | 2025-09-02 08:08:22 |
| About_Gelakte gegevens_linkhref_1 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-02 08:08:22 |
| About_Type bronbestand | PDF, 13 pagina's | 2025-06-30 04:09:56 |
| About_Type bronbestand_paginas | 13 | 2025-06-30 04:09:56 |
| About_Download als | PDF (6.22 MB) | 2025-06-30 04:09:56 |
| About_Documentnummer | 663263 | 2025-06-30 04:09:56 |
| About_Beoordeling | Openbaarmaking | 2025-06-30 04:09:56 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 25 februari 2022 een besluit genomen op verzoeken in het kader van de Wet openbaarheid van bestuur. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en medicatie over de periode september 2020. | 2025-06-30 04:09:56 |
| Request_Type besluit | Wob-besluit | 2025-06-30 04:09:56 |
| Request_Datum besluit | 25 februari 2022 | 2025-06-30 04:09:56 |
| document_SectionHistory | 1 | 2025-06-30 04:09:56 |
| Request_Omvang openbaarmaking_paginas | 23.793 | 2025-06-30 04:09:56 |
| document_documentType | 2025-06-30 04:09:56 | |
| document_documentPublicationDate | 2020-09-10 | 2025-06-30 04:09:56 |
| document_documentNumber | VWS-WOO-08-663263 | 2025-06-30 04:09:56 |
| document_SectionHTMLDataDivs | 3 | 2025-06-30 04:09:56 |
| document_SectionAbout | 1 | 2025-06-30 04:09:56 |
| About_Datum document | 10 september 2020 | 2025-06-30 04:09:56 |
| Request_Omvang openbaarmaking | 8.330 documenten, 23.793 pagina's Inventarislijst | 2025-06-30 04:09:56 |
| Request_Omvang openbaarmaking_documenten | 8.330 | 2025-06-30 04:09:56 |
| document_documentName | Centrient Pharmaceuticals_EU pharma strategy response_Final Draft.pdf | 2025-06-30 04:09:56 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/file/download/inventory | 2025-06-30 04:09:56 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-30 04:09:56 |
| document_SectionDownloadButton | 0 | 2025-06-30 04:09:56 |
| About_Gelakte gegevens | Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-30 04:09:56 |
| About_Gelakte gegevens_linkhref_1 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over Centrient Pharmaceuticals_EU pharma strategy response_Final Draft.pdf (documentnummer 1ef8fb29-39ba-62aa-8944-fb42b720b124) | 2025-06-30 04:09:56 |
| About_Gelakte gegevens_linkname_1 | Laat het ons weten | 2025-06-30 04:09:56 |
| document_SectionRequest | 1 | 2025-06-30 04:09:56 |
| Request_Onderdeel van | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode september 2020 | 2025-06-30 04:09:56 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz | 2025-06-30 04:09:56 |
| Request_Onderdeel van_linkname_1 | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode september 2020 | 2025-06-30 04:09:56 |
| Request_Periode | September 2020 | 2025-06-30 04:09:56 |
| History Actie_1 | Bronbestand toegevoegd (pdf, 6.22 MB) | 2025-06-21 02:20:46 |
| History Datum_1 | 21 oktober 2024 16:31 | 2025-06-21 02:20:46 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/file/download/document/1ef8fb29-39ba-62aa-8944-fb42b720b124 | 2025-04-19 13:36:12 |
| DocumentDownload_linkname | Download (pdf, 6.22 MB) | 2025-04-19 13:36:12 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-663263.pdf | 2025-04-19 13:36:12 |
Archiefversies (9 rijen)
Archiefrij 1 — 2025-11-21 15:27:21
fromFile: VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip
fromFilePath: archieven_files\VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip
documentName: VWS-WOO-08-663263.pdf
documentType: pdf
documentCompressedSize: 4786854
documentSize: 6520007
documentCompressRatio: 73.41792731204123
documentDateModified: 2025-10-09 13:18:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:27:21
lastSeen: 2025-11-21 15:27:21
text: 663263
Survey on the Pharmaceutical Strategy Timely
patient access to affordable medicines
Fields marked with
are
mandatory
Introduction
The EU strives to be a frontrunner in ensuring universal health coverage In addition it is a global leader in
healthcare research and development and a major t...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 41195857c6f97313b6b9258da968824caa80f12e327d3d9337434759f450ec48
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 4762b6a4-dc85-4081-a2aa-5300e202fcb7
textDigestSHA256: 7749313d98ea76471b4af6d1405b5c4907a36749cf1cad6608512a173e75fd51
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-663263
Archiefrij 2 — 2025-11-21 15:15:27
fromFile: VWS-WOO-3324842-1025145-wjz-1f0a5111-2d47-6b86-928b-b52ef042b7e3.zip
fromFilePath: archieven_files\VWS-WOO-3324842-1025145-wjz-1f0a5111-2d47-6b86-928b-b52ef042b7e3.zip
documentName: VWS-WOO-08-663263.pdf
documentType: pdf
documentCompressedSize: 4786854
documentSize: 6520007
documentCompressRatio: 73.41792731204123
documentDateModified: 2025-10-09 13:18:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:15:27
lastSeen: 2025-11-21 15:15:27
text: 663263
Survey on the Pharmaceutical Strategy Timely
patient access to affordable medicines
Fields marked with
are
mandatory
Introduction
The EU strives to be a frontrunner in ensuring universal health coverage In addition it is a global leader in
healthcare research and development and a major t...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 41195857c6f97313b6b9258da968824caa80f12e327d3d9337434759f450ec48
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: c1ca2b19-e5d5-4cb0-b26a-6cd6fefabe16
textDigestSHA256: 7749313d98ea76471b4af6d1405b5c4907a36749cf1cad6608512a173e75fd51
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-663263
Archiefrij 3 — 2025-09-08 18:29:09
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/temp/VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf
documentName: VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 6520007
documentCompressRatio: 0
documentDateModified: 2025-09-08 18:29:09
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-08 18:29:09
lastSeen: 2025-09-08 18:29:09
text: 663263
Survey onthe Pharmaceutical Strategy Timely
patient access toaffordable medicines
Fields marked with aremandatory
Introduction
The EUstrives tobeafrontrunner inensuring universal health coverage Inaddition itisaglobal leader in
healthcare research anddevelopment and amajor trading partner inp...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 41195857c6f97313b6b9258da968824caa80f12e327d3d9337434759f450ec48
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: folder_import_52331_e3698d317e58945093e0d968b78082d1
textDigestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-663263
Archiefrij 4 — 2025-09-07 17:23:28
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-663263.pdf
documentName: VWS-WOO-08-663263.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 6520007
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:23:28
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:23:28
lastSeen: 2025-09-07 17:23:28
text: 663263
Survey onthe Pharmaceutical Strategy Timely
patient access toaffordable medicines
Fields marked with aremandatory
Introduction
The EUstrives tobeafrontrunner inensuring universal health coverage Inaddition itisaglobal leader in
healthcare research anddevelopment and amajor trading partner inp...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 41195857c6f97313b6b9258da968824caa80f12e327d3d9337434759f450ec48
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: folder_import_37117_9d1f6361d0b1cad88fabeab400a9f86a
textDigestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-663263
Archiefrij 5 — 2025-09-04 16:18:27
fromFile: VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip
documentName: VWS-WOO-08-663263.pdf
documentType: pdf
documentCompressedSize: 4786854
documentSize: 6520007
documentCompressRatio: 73.41792731204123
documentDateModified: 2025-05-01 21:07:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:18:27
lastSeen: 2025-11-21 13:47:41
text: 663263
Survey onthe Pharmaceutical Strategy Timely
patient access toaffordable medicines
Fields marked with aremandatory
Introduction
The EUstrives tobeafrontrunner inensuring universal health coverage Inaddition itisaglobal leader in
healthcare research anddevelopment and amajor trading partner inp...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 41195857c6f97313b6b9258da968824caa80f12e327d3d9337434759f450ec48
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip_2904
textDigestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-663263
Archiefrij 6 — 2025-05-22 11:41:58
fromFile: VWS-WOO-3324842-1025145-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3324842-1025145-wjz.zip
documentName: VWS-WOO-08-663263.pdf
documentType: pdf
documentCompressedSize: 4786854
documentSize: 6520007
documentCompressRatio: 73.41792731204123
documentDateModified: 2025-05-01 21:07:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-05-22 11:41:58
lastSeen: 2025-05-22 11:41:58
text: 663263
Survey onthe Pharmaceutical Strategy Timely
patient access toaffordable medicines
Fields marked with aremandatory
Introduction
The EUstrives tobeafrontrunner inensuring universal health coverage Inaddition itisaglobal leader in
healthcare research anddevelopment and amajor trading partner inp...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 423294
textDigestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-663263
Archiefrij 7 — 2025-02-27 09:25:02
fromFile: 2023.057-VWS-WOO-3324842-1025145-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3324842-1025145-wjz.zip
documentName: VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf
documentType: pdf
documentCompressedSize: 4777095
documentSize: 6520007
documentCompressRatio: 73.26824955862777
documentDateModified: 2024-12-10 12:03:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:02
lastSeen: 2025-02-27 09:25:02
text: 663263
Survey onthe Pharmaceutical Strategy Timely
patient access toaffordable medicines
Fields marked with aremandatory
Introduction
The EUstrives tobeafrontrunner inensuring universal health coverage Inaddition itisaglobal leader in
healthcare research anddevelopment and amajor trading partner inp...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 217883
textDigestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-663263
Archiefrij 8 — 2025-02-18 12:36:08
fromFile: Besluit__dossier_nr_-84c6bdd4cd39ee1cd5963f471af3a703ee779472f5812544c3ddaaa2fdb0ccdf.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-84c6bdd4cd39ee1cd5963f471af3a703ee779472f5812544c3ddaaa2fdb0ccdf.zip
documentName: VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf
documentType: pdf
documentCompressedSize: 4777095
documentSize: 6520007
documentCompressRatio: 73.26824955862777
documentDateModified: 2024-12-04 10:54:52
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:36:08
lastSeen: 2025-02-18 12:36:08
text: 663263
Survey onthe Pharmaceutical Strategy Timely
patient access toaffordable medicines
Fields marked with aremandatory
Introduction
The EUstrives tobeafrontrunner inensuring universal health coverage Inaddition itisaglobal leader in
healthcare research anddevelopment and amajor trading partner inp...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 178460
textDigestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-663263
Archiefrij 9 — 2025-02-18 12:18:03
fromFile: Besluit__dossier_nr_-1fe8423d31374d5a01c39858dd27b6af41ab93aac5ab9c6c9d8d782357487917.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-1fe8423d31374d5a01c39858dd27b6af41ab93aac5ab9c6c9d8d782357487917.zip
documentName: VWS-WOO-08-663263-Centrient_Pharmaceuticals_EU_pharma_strategy_response_Final_Draft.pdf
documentType: pdf
documentCompressedSize: 4777095
documentSize: 6520007
documentCompressRatio: 73.26824955862777
documentDateModified: 2024-10-21 17:06:10
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:03
lastSeen: 2025-02-18 12:18:03
text: 663263
Survey onthe Pharmaceutical Strategy Timely
patient access toaffordable medicines
Fields marked with aremandatory
Introduction
The EUstrives tobeafrontrunner inensuring universal health coverage Inaddition itisaglobal leader in
healthcare research anddevelopment and amajor trading partner inp...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: 54107
textDigestSHA256: a092e3fdd2e125d7044393751ce354239cb9435ec1b7676d719b7846d61fb11c
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-663263
(dit is ook een speeltuin)